Letrozole Clinical Trials in Cincinnati, OH
As of October 2026, 1 paid clinical trial is testing Letrozole in Cincinnati, Ohio. Trials typically compensate participants for time, travel, and study visits, and many also provide study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial testing Letrozole
Top Research Study Locations in Cincinnati
Researchers run research studies in Cincinnati, OH at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cincinnati Children's Hospital Medical Center | Neuroblastoma, Diffuse Intrinsic Pontine Glioma, High Grade Glioma | 268 |
| University of Cincinnati | Chronic Lymphocytic Leukemia, Stroke, Multiple Myeloma | 101 |
| University of Cincinnati Medical Center | Advanced Solid Tumor, Interstitial Lung Disease, Stroke | 69 |
| Cincinnati Children's Hospital | Amblyopia, Musculoskeletal Pain, Acute Kidney Injury | 49 |
| The Christ Hospital | Tricuspid Regurgitation, Heart Failure, Advanced Solid Tumor | 44 |
| University of Cincinnati Cancer Center-UC Medical Center | Stage III Laryngeal Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | 40 |
| Bethesda North Hospital | Malignant Solid Neoplasm, Ovarian Carcinoma, Plasma Cell Myeloma | 30 |
| Good Samaritan Hospital - Cincinnati | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Anatomic Stage I Breast Cancer AJCC v8 | 30 |
| TriHealth Cancer Institute-Anderson | Malignant Solid Neoplasm, Ovarian Carcinoma, Plasma Cell Myeloma | 23 |
| TriHealth Cancer Institute-Westside | Malignant Solid Neoplasm, Ovarian Carcinoma, Plasma Cell Myeloma | 23 |
| Cincinnati Eye Institute | Stargardt Disease, Cone Rod Dystrophy, Juvenile Macular Degeneration | 15 |
| CTI Clinical Research Center | Obesity, Overweight, Obstructive Sleep Apnoea | 12 |
| Oncology Hematology Care | Multiple Myeloma, Breast Cancer, Acute Myeloid Leukemia (AML) | 12 |
| Oncology Hematology Care Inc-Kenwood | Acral Lentiginous Melanoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 11 |
| University of Cincinnati College of Medicine | Acetabular Fracture, Acupuncture, Adolescents | 10 |
| Good Samaritan Hospital | Atrial Fibrillation, Chronic Subdural Hematoma, Deep Vein Thrombosis | 8 |
| University of Cincinnati Cancer Center | Colorectal Cancer, ALK-Positive Lung Cancer, ALK-positive NSCLC | 8 |
| Children's Hospital Medical Center | Biliary Atresia, Duchenne Muscular Dystrophy, Essential Fatty Acid Deficiency | 7 |
| Cincinnati Childrens Hospital Medical Center | Adrenal Insufficiency, Alopecia, Areata Alopecia | 7 |
| GSK Investigational Site | Asthma, Chickenpox, Colonic Neoplasms | 6 |
| Alkermes Investigational Site | Narcolepsy Type 1, Narcolepsy Type 2, Bipolar I Disorder | 5 |
| Christ Hospital | Acute or Chronic Coronary Artery Disease, Cardiovascular Diseases, Coronary Artery Disease | 5 |
| Cincinnati Children's Medical Center | Infant, Small for Gestational Age, Infant, Low Birth Weight, Infant, Newborn | 5 |
| Cinn Children Hosp Medical Center | Chronic Myelogenous Leukemia, Cryptosporidiosis, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive | 5 |
| The Christ Hospital Cancer Center | Advanced Adenocarcinoma, Breast Cancer, Extensive-stage Small-cell Lung Cancer | 5 |
Active & Upcoming Studies in Cincinnati (2026)
Recruiting trials in Cincinnati grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (286 active studies)
- Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05) · Phase 3 · AstraZeneca
- A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer · Children's Hospital Medical Center, Cincinnati
Cardiovascular (92 active studies)
- Adapting Enhanced Supports to Improve Patient Adherence to Secondary Antibiotic Prophylaxis for Rheumatic Heart Disease · Children's Hospital Medical Center, Cincinnati
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
Neurology & pain (67 active studies)
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
- Cilostazol for Prevention of Recurrent Stroke Trial · Phase 3 · Stanford University
Diabetes & metabolic (40 active studies)
- GLP-1 RA for Stage 1 Type 1 Diabetes · Phase 2 · Children's Hospital Medical Center, Cincinnati
- A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity · Phase 3 · Novo Nordisk A/S
Pediatric (35 active studies)
- Adapting Enhanced Supports to Improve Patient Adherence to Secondary Antibiotic Prophylaxis for Rheumatic Heart Disease · Children's Hospital Medical Center, Cincinnati
- Asthma Ctrl SMART Trial · Children's Hospital Medical Center, Cincinnati
Mental health & behavior (22 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
Eye & vision (15 active studies)
- A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions · Phase 1 · Astellas Institute for Regenerative Medicine
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
Vaccines (12 active studies)
- Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19 · Phase 4 · Sanofi
- A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
HIV / STI (7 active studies)
- Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver) · Johns Hopkins University
- Study of GS-0415 and How It Works in People With HIV · Phase 1 · Gilead Sciences
Common conditions studied in Cincinnati
- Obesity (22 active studies)
- Heart Failure (19 active studies)
- Overweight (14 active studies)
- Breast Cancer (11 active studies)
- Multiple Myeloma (11 active studies)
- Cystic Fibrosis (10 active studies)
Leading research sponsors in Cincinnati
- Children's Hospital Medical Center, Cincinnati
- University of Cincinnati
- National Cancer Institute (NCI)
- AstraZeneca
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Cincinnati?
There are approximately 1,077 recruiting clinical trials in Cincinnati, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Cincinnati pay participants?
Most recruiting trials in Cincinnati compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Cincinnati?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Cincinnati?
The most common conditions under active study in Cincinnati include Obesity (22), Heart Failure (19), Overweight (14), Breast Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Cincinnati?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Cincinnati on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Cincinnati?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Cincinnati?
Recruiting research sites in Cincinnati include Cincinnati Children's Hospital Medical Center, University of Cincinnati, University of Cincinnati Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Cincinnati right now?
The largest active categories in Cincinnati are Cancer & tumors (286), Cardiovascular (92), Neurology & pain (67). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.